These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16734940)

  • 1. Association of the dopamine receptor interacting protein gene, NEF3, with early response to antipsychotic medication.
    Strous RD; Greenbaum L; Kanyas K; Merbl Y; Horowitz A; Karni O; Viglin D; Olender T; Deshpande SN; Lancet D; Ben-Asher E; Lerer B
    Int J Neuropsychopharmacol; 2007 Jun; 10(3):321-33. PubMed ID: 16734940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the RGS2 gene with extrapyramidal symptoms induced by treatment with antipsychotic medication.
    Greenbaum L; Strous RD; Kanyas K; Merbl Y; Horowitz A; Karni O; Katz E; Kotler M; Olender T; Deshpande SN; Lancet D; Ben-Asher E; Lerer B
    Pharmacogenet Genomics; 2007 Jul; 17(7):519-28. PubMed ID: 17558307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of tryptophan hydroxylase 2 (TPH2) in schizophrenia and in the response to antipsychotics.
    Schuhmacher A; Becker T; Rujescu D; Quednow BB; Lennertz L; Wagner M; Benninghoff J; Rietschel M; Häfner H; Franke P; Wölwer W; Gaebel W; Maier W; Mössner R
    J Psychiatr Res; 2012 Aug; 46(8):1073-80. PubMed ID: 22655589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the dopamine D3 receptor (DRD3) gene polymorphisms on risperidone response: a pharmacogenetic study.
    Xuan J; Zhao X; He G; Yu L; Wang L; Tang W; Li X; Gu N; Feng G; Xing Q; He L
    Neuropsychopharmacology; 2008 Jan; 33(2):305-11. PubMed ID: 17429404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RGS4 polymorphisms predict clinical manifestations and responses to risperidone treatment in patients with schizophrenia.
    Lane HY; Liu YC; Huang CL; Chang YC; Wu PL; Huang CH; Tsai GE
    J Clin Psychopharmacol; 2008 Feb; 28(1):64-8. PubMed ID: 18204343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine (DRD2) and Serotonin (HTR2A, 2C) Receptor Gene Polymorphisms do not influence early response to Risperidone in South Indian Patients with Schizophrenia.
    Alladi CG; RajKumar RP; Adithan S; Marie-Claire C; Bellivier F; Shewade DG
    Fundam Clin Pharmacol; 2019 Jun; 33(3):355-364. PubMed ID: 30332506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dopamine D2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function.
    Lane HY; Lee CC; Chang YC; Lu CT; Huang CH; Chang WH
    Int J Neuropsychopharmacol; 2004 Dec; 7(4):461-70. PubMed ID: 15140279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
    Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
    Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment.
    Gupta M; Bhatnagar P; Grover S; Kaur H; Baghel R; Bhasin Y; Chauhan C; Verma B; Manduva V; Mukherjee O; Purushottam M; Sharma A; Jain S; Brahmachari SK; Kukreti R
    Pharmacogenomics; 2009 Mar; 10(3):385-97. PubMed ID: 19290789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia.
    Ikeda M; Yamanouchi Y; Kinoshita Y; Kitajima T; Yoshimura R; Hashimoto S; O'Donovan MC; Nakamura J; Ozaki N; Iwata N
    Pharmacogenomics; 2008 Oct; 9(10):1437-43. PubMed ID: 18855532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the influence of dopamine D₂ polymorphisms and plasma drug concentrations on the clinical response to risperidone.
    Yasui-Furukori N; Tsuchimine S; Saito M; Nakagami T; Sugawara N; Fujii A; Kaneko S
    J Clin Psychopharmacol; 2011 Oct; 31(5):633-7. PubMed ID: 21869689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled, clinical trial.
    Hosseini SM; Farokhnia M; Rezaei F; Gougol A; Yekehtaz H; Iranpour N; Salehi B; Tabrizi M; Tajdini M; Ghaleiha A; Akhondzadeh S
    Eur Neuropsychopharmacol; 2014 Jun; 24(6):846-55. PubMed ID: 24636461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine transporter polymorphisms and risperidone response in Chinese schizophrenia patients: an association study.
    Zhang A; Xing Q; Wang L; Du J; Yu L; Lin Z; Li X; Feng G; He L
    Pharmacogenomics; 2007 Oct; 8(10):1337-45. PubMed ID: 17979508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of the ABCB1 gene are associated with the therapeutic response to risperidone in Chinese schizophrenia patients.
    Xing Q; Gao R; Li H; Feng G; Xu M; Duan S; Meng J; Zhang A; Qin S; He L
    Pharmacogenomics; 2006 Oct; 7(7):987-93. PubMed ID: 17054409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association analysis of serotonin receptor 7 gene (HTR7) and risperidone response in Chinese schizophrenia patients.
    Wei Z; Wang L; Xuan J; Che R; Du J; Qin S; Xing Y; Gu B; Yang L; Li H; Li J; Feng G; He L; Xing Q
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):547-51. PubMed ID: 19233240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial treatment of severe acute psychosis with fast orally disintegrating risperidone tablets.
    Normann C; Schmauss M; Bakri N; Gerwe M; Schreiner A
    Pharmacopsychiatry; 2006 Nov; 39(6):209-12. PubMed ID: 17124642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse effects of risperidone on spatial working memory in first-episode schizophrenia.
    Reilly JL; Harris MS; Keshavan MS; Sweeney JA
    Arch Gen Psychiatry; 2006 Nov; 63(11):1189-97. PubMed ID: 17088499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open-label, randomized, controlled trial of zotepine and risperidone for acutely ill, hospitalized, schizophrenic patients with symptoms of agitation.
    Chan HY; Lin AS; Chen KP; Cheng JS; Chen YY; Tsai CJ
    J Clin Psychopharmacol; 2013 Dec; 33(6):747-52. PubMed ID: 24100785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
    Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
    Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.